Supplement use during an intergroup clinical trial for breast cancer (S0221)

The use of supplements during chemotherapy is controversial, partly due to the potential effect of antioxidants on reduced efficacy of chemotherapy-related cytotoxicity. We examined supplement use among breast cancer patients registered to a clinical trial (SWOG 0221) before diagnosis and during tre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Zirpoli, Gary R., Brennan, Patrick M., Hong, Chi-Chen, McCann, Susan E., Ciupak, Gregory, Davis, Warren, Unger, Joseph M., Thomas Budd, G., Hershman, Dawn L., Moore, Halle C.F., Stewart, James, Isaacs, Claudine, Hobday, Timothy, Salim, Muhammad, Hortobagyi, Gabriel N., Gralow, Julie R., Albain, Kathy S., Ambrosone, Christine B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2013
Soggetti:
Epidemiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3552360/
https://ncbi.nlm.nih.gov/pubmed/23306462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2400-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi